comparemela.com

James Januzzi Jr News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Proof of Benefit in Acute MI Again Evades an SGLT2 Inhibitor

Yet empagliflozin gets a boost from a lower risk of total HF events in EMPACT-HF

United statesBaylor scottJames januzzi jrPatrick ogaraJaved butlerNicole louWhite research instituteAmerican college of cardiologyHarvard medical schoolAmerican collegeNew england journalMassachusetts general hospitalMedpage todayEngland journalEnglj med

CASTLE-HTx: AF Ablation Boosts Outcomes in Advanced Heart Failure

Despite some limitations, “the totality of evidence really points towards a benefit,” James Januzzi says.

Nordrhein westfalenUnited statesBad oeynhausenNoord hollandJames januzziDiabeteszentrum nordrhein westfalenFinn gustafssonJames januzzi jrChristian sohnsPhilipp sommerAmerican college of cardiologyCopenhagen university hospitalEuropean society of cardiology congressEuropean societyCardiology congressNew england journal

SGLT2 Inhibitors Curb AF Post-Ablation Recurrences in T2D

Retrospective, observational data from more than 13,000 US patients with type 2 diabetes and atrial fibrillation suggest that SGLT2 inhibitor treatment may cut AF recurrences post-ablation.

United statesJames januzzi jrDivision of cardiovascular medicineTrinetx analytics networkBeth israel lahey healthCardiovascular medicineLahey hospitalMedical centerDiabetes mellitus type 2Iabetes mellitus type iiType 2 diabetesAtrial fibrillationF atrial fibrillationSglt2 inhibitorsOdium glucose transporter 2 inhibitorsOdium glucose co transporter 2 inhibitors

Lower Entresto Doses Suffice in the Real World

Reassuring findings for patients who don't tolerate the maximum ARNI dose

United statesColl cardiolNicole louMary norine walshJames januzzi jrJournal of the american college cardiologyHarvard medical schoolVincent heart centerCity cardiomyopathy questionnaireJames januzziMassachusetts general hospitalAmerican collegeMedpage today

GDMT With ARNI Linked to Less MR, May Obviate Need for Interventions

Before TEER or surgery, patients with MR should be optimized on GDMT with sacubitril/valsartan for at least 6 months, say experts.

United statesMitraclip abbottJamesl januzzi jrLos angelesGregg fonarowJames januzzi jrG michael felkerHeart failure society of americaMd university of californiaMd duke clinical research instituteMassachusetts general hospitalHeart failure societyDuke clinical research institute

vimarsana © 2020. All Rights Reserved.